When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued ...
By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharmaceutical and diagnostics giant Roche ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise their workflows and explore a wider array of ...
Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...
Elizabeth Dennis describes the testing process following a new lung cancer diagnosis. Initial tissue biopsy is sent for next-generation sequencing (NGS), although repeat tissue sampling or liquid ...
The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results